Clinical Trial Update: First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

This first-in-human Phase 1 trial update reports safety, tolerability, and pharmacokinetics data for LHA510 in elderly participants and patients with Age-Relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• LHA510

Snippet

Sponsor: Alcon Research | Conditions: Age-Related Macular Degeneration | Phase 1 | Status: COMPLETED | Results posted: 2015-09-04